James R Burton
Affiliation: Oregon Health and Science University
- Liver transplantation in mushroom poisoningJames R Burton
Department of Medicine, GI Unit Hepatology Section Strong, Memorial Hospital, Rochester, New York, USA
J Clin Gastroenterol 35:276-80. 2002..We present a case of FHF related to mushroom poisoning that required liver transplantation. The clinical presentation, medical management, and prognostic criteria in mushroom poisoning are discussed...
- Use of hepatitis B core antibody-positive donors in recipients without evidence of hepatitis B infection: a survey of current practice in the United StatesJames R Burton
Division of Gastroenterology Hepatology, Oregon Health and Sciences University, Portland, OR 97239, USA
Liver Transpl 9:837-42. 2003..Treatment protocols for using these organs varied. Knowledge about HBV DNA status of the donor and/or liver would greatly influence prophylaxis for those accepting anti-HBc(+) donor livers...
- Retransplantation for recurrent hepatitis C in the MELD era: maximizing utilityJames R Burton
Division of Gastroenterology Hepatology, Oregon Health and Science University, Portland, OR, USA
Liver Transpl 10:S59-64. 2004..Utility starts to decline at MELD scores above 28. 5. The current allocation system (MELD) fails to maximize utility with regard to re-LT...
- Liver retransplantation for hepatitis C virus recurrence: a survey of liver transplant programs in the United StatesJames R Burton
Division of Gastroenterology Hepatology, Oregon Health and Science University and Portland Veterans Administration Medical Center, Portland, Oregon 97239, USA
Clin Gastroenterol Hepatol 3:700-4. 2005..To gain insight into how transplant centers are dealing with this issue and whether published prognostic factors are being used, we conducted a survey of liver transplant centers across the US in late 2003...
- Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis CNorah A Terrault
Department of Medicine, University of California San Francisco, San Francisco, California 94143 0538, USA
Clin Gastroenterol Hepatol 6:1403-11. 2008..Prior studies suggest the rate of liver fibrosis progression is slower in African Americans (AAs) than Caucasian Americans (CAs) with chronic HCV infection...
- Treatment of HCV recurrence: do the pretransplantation rules apply?James R Burton
Liver Transpl 12:1044-8. 2006
- Retransplantation for hepatitis C: what do we really know?James R Burton
Liver Transpl 10:1504-6. 2004
- Retransplantation for hepatitis C: results of a U.S. multicenter retransplant studyTimothy McCashland
Department of Hepatology, University of Nebraska Medical Center, Omaha, NE 68198 3285, USA
Liver Transpl 13:1246-53. 2007..MELD scores were not predictive of post-reTX survival. Survival was <50% in the non-HCV reTx group with MELD score of >30. Many patients with recurrent HCV are not considered for reTX and die from recurrent disease...
- Acute rejection in HCV-infected liver transplant recipients: The great conundrumJames R Burton
Division of Gastroenterology and Hepatology, Liver Transplantation Program and Hepatitis C Research Center, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA
Liver Transpl 12:S38-47. 2006..6. Mild rejection per se is not associated with graft loss and treatment of rejection with steroids and OKT3 is associated with worse outcome in HCV; thus, it seems logical that we should no longer treat mild rejection...
- Diagnosis and management of allograft failureJames R Burton
Division of Gastroenterology and Hepatology, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, B154, Denver, CO 80262, USA
Clin Liver Dis 10:407-35, x. 2006..It also discusses the complex problems involved in retransplantation for allograft failure...
- Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistenceLucy Golden-Mason
Division of Gastroenterology and Hepatology, Hepatitis C Center, and Integrated Program in Immunology, University of Colorado Health Sciences Center and National Jewish Hospital, Denver, CO, USA
Hepatology 44:1098-109. 2006..These data provide a mechanistic basis for the observation that CTLs generated in early infection rapidly decline as chronicity is established; CD127 expression should be considered in the design of novel immunotherapeutic approaches...
- Validation of a multivariate model predicting presence and size of varicesJames R Burton
Division of Gastroenterology and Hepatology, University of Colorado Health Sciences University, Denver, CO 80262, USA
J Clin Gastroenterol 41:609-15. 2007..A model developed by our group identified low platelets and advanced Child-Pugh class (CPC) as being associated with large varices...
- Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapyHugo R Rosen
Integrated Program in Immunology and Hepatitis C Research Center, Division of Gastroenterology and Hepatology, University of Colorado, Denver, CO, USA
Hepatology 46:350-8. 2007..007). ELISPOT response was independently associated with SVR by multivariable analysis...
- Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infectionSusan Smyk-Pearson
Division of Gastroenterology and Hepatology, Hepatitis C Center, University of Colorado Health Sciences Center, GI Division, 4200 E 9th Ave, B 158, Denver, CO 80262, USA
J Infect Dis 197:46-57. 2008....